User

Dabur stock performance

Asked by CNI Follower · 3 months ago · 13-12-2025

Dabur India Ltd (NSE: DABUR) has delivered modest business growth but relatively weak stock price performance over the last 3–5 years, with valuations still on the richer side.

1. Current market picture (recent)

- Recent share price: ~₹505 per share (latest available data; Torus Digital, updated ~3 days ago). (torusdigital.com)

- 52‑week range: ₹433 – ₹577. (torusdigital.com)

- Market cap: Mid-cap FMCG. (marketsmojo.com)

2. Recent return profile

(Price performance; not a recommendation)

```html

PeriodPrice Return (Dabur)Total Return (Price + Dividend)
1 Month≈ -3.2%
YTD (2025)≈ -1.2%
1 Year≈ -4.2%≈ -2.7%
3 Years≈ -16.9%≈ -13.5%
5 Years≈ -0.2%Higher (helped by dividends)

```

Source: MarketsMojo as of 8 Dec 2025 (price ~₹502). (marketsmojo.com)

Additional comparison: over the latest 1‑year period, Dabur’s return was around –0.6% vs Nifty 50 at +5% (Torus Digital), indicating underperformance vs the index. (torusdigital.com)

Dividend yield: around 1.5–1.6% on current price. (marketsmojo.com)

3. Business performance & fundamentals (up to FY25)

- Revenue growth: Net sales have grown from ~₹8,533 crore (FY2019) to ~₹12,563 crore (FY2025), implying ~7.5% CAGR over 6 years. (marketsmojo.com)

- Profit trend: FY2025 PAT was ~₹1,740 crore, slightly down vs FY2024 (~₹1,843 crore), indicating some margin/earnings pressure despite higher sales. (marketsmojo.com)

- Operating margins: Largely stable; operating margin has moved in the 18–21% band over the last several years (18.4% in FY2025 vs a peak ~21% in FY2021). (marketsmojo.com)

This suggests a steady but not high-growth FMCG business, with recent years seeing slower profit growth and some margin compression.

4. Latest quarterly performance (Q2 FY26 – Sep 2025)

- Revenue: ~₹3,191 crore, up ~5.3–5.4% YoY. (financialexpress.com)

- Net profit: ~₹445 crore, up ~6.5% YoY. (financialexpress.com)

- EBITDA margin: around 18.4%, slightly better YoY. (businessupturn.com)

- Dividend: interim dividend of ₹2.75 per share declared. (financialexpress.com)

Despite this decent quarter, the stock fell ~2.2% to ~₹490 on 31 Oct 2025 post-results, with brokerages generally maintaining “Neutral/Reduce” stances and target prices around ₹500–₹525. (m.economictimes.com)

5. Valuation snapshot

- As of early November 2025, Dabur was trading near ₹517 with a P/E around 50x TTM earnings, significantly above typical market multiples and high even within FMCG. (gurufocus.com)

This indicates that despite moderate earnings growth (mid‑single to high‑single digit), the stock still commands a premium valuation.

6. Interpretation of performance (examples, not advice)

- Example lens 1 (valuation-sensitive investor):

- Price has underperformed over 3–5 years, while the business has grown modestly (~7–8% revenue CAGR).

- With the stock still around 50x earnings and only mid‑single‑digit recent growth, such an investor might judge that a lot of optimism is already priced in and prefer either a lower entry price or faster growth before getting interested.

- Example lens 2 (long‑term FMCG/Ayurveda believer):

- Dabur remains a strong brand franchise in healthcare, oral care, and beverages, with stable margins and healthy cash generation. (tgnns.com)

- Such an investor might view the recent price consolidation (well below the 52‑week high of ₹577) as a phase of time correction rather than deep value, and may focus more on long‑term brand and distribution strength than on near‑term underperformance.

For live prices or more granular charts, you can refer to NSE/BSE, Moneycontrol, or Sites like MarketsMojo and Torus Digital:

- Dabur India total returns & charts: MarketsMojo. (marketsmojo.com)

- Live quote & basic fundamentals: Torus Digital. (torusdigital.com)

If you share your investment horizon (short term vs 3–5 years) and risk profile, one can frame this same data very differently, but any final buy/hold/sell action should be taken with your advisor based on your personal situation.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com